Connect with us

Uncategorized

Corona Risk after Vaccination: Corona, Poonawala explain reason for people getting vaccine

Published

on

Corona Risk after Vaccination: Corona, Poonawala explain reason for people getting vaccine
Corona Risk after Vaccination: Corona, Poonawala explain reason for people getting vaccine

Corona Risk after Vaccination: Corona, Poonawala explain reason for people getting vaccine

Corona Risk after Vaccination: It is being investigated in several countries following complaints of blood clotting coming into the Astrazeneca-Oxford vaccine. Interestingly, the Pune-based Serum Institute is the largest manufacturer of the vaccine, which is being given to people in India as well. In view of this, the company’s CEO Adar Poonawala in an exclusive interview to India Today has tried to answer the side effects of the vaccine and all the questions arising out of it.

Photo Credit: Getty Images

अदार पूनावाला 10

Corona Risk after Vaccination: Corona, Poonawala explain reason for people getting vaccine

Many people have turned corona positive even after getting vaccinated. Adar Poonawala said, ‘I call it covid shield because it is a kind of shield that will not protect you from getting sick, but you are not going to die because of it. It protects you from serious illness and will prevent you from going to the hospital even after taking a dose in 95% of cases. Like in a bullet proof jacket, when you get a bullet, you don’t die because of a bullet proof jacket, but you get a little damage. Since January, we have given a dose of corona vaccine to nearly 40 million people, now we have to see if they are being hospitalized.’

अदार पूनावाला 11

On the original idea of the vaccine, Adar Poonawala said, ‘I or any other vaccine company have never claimed that the vaccine will not allow you to get sick. Maybe there’s been such a perception among people. If you look at today and other vaccines, there are very few vaccines that protect you from illness or infection, but they protect you. Who is also of the opinion that you should be right and therefore everyone needs vaccination. The claim to protect us from illness must never have been our goal post or anyone from the scientific community. Today, there are many medicines that once worked but no longer do. As of today there is nothing created by humans that is 100%. It works many times but not always.’

Photo Credit: Getty Images

अदार पूनावाला 2

 Speaking on complaints of clotting in Europe over the Astrazeneca vaccine, Adar Poonawala said, “Since the time of its clinical trial, questions have been raised about its impact and neurological impact, and now it is a case of blood clotting. But we have been asking from the beginning that regulators and vaccine investigators should be allowed to complete the investigation of the case and then let them arrive at a logical conclusion. Not to talk about the debate in the media or the company’s claim. The Health Ministry in India, who, EMEA and other countries said the vaccine is completely safe. I won’t make a statement on this blood clotting case right now because the full report may come next week. We should wait for him.’

Photo Credit: Getty Images

अदार पूनावाला 3

One thing that has always been observed about the adverse effects of the vaccine is that there is another reason for it, said Adar Poonawala. Blood clotting is common in the age of people who have been vaccinated. So we have to see if there has been a sudden increase in blood clotting among vaccine recipients in European countries. We can then link it as a side effect from the vaccine. As far as India is concerned, here we have not received any report on blood clotting due to vaccine.

He said, “In India, we have found that those who were covided and hospitalized were given covidshield vaccine and it saw its efficiency not 2 or 3% but more than 90% of the people, that too with just one dose. It recognizes a Scottish study that found out how effective a single dose of covidshield is among more than 4 00,000 people.

Photo Credit: Getty Images

अदार पूनावाला 4

On the growing concern among people about the vaccine, Adar Poonawala said, “I believe that people’s concerns are justified, because if people are reading about these reports, they don’t know what is happening. But as far as the ban on the Astrazeneca Oxford vaccine is concerned, all other countries, including Germany, have approved its vaccine back. So it’s not a ban on the vaccine but a temporary review. For regulators, it is a way of checking the safety of the vaccine, which is also true. Even EMEA, WHO and UKMHRA have not banned the vaccine nor described it as unsafe. All this can’t be wrong. In India too, serum has supplied millions of vaccine supplements to the government and nearly 70 million doses have been given to people and we have not seen any such case in India. But it is good that countries are reviewing for the safety of the people and then later approving the emergency use of the vaccine again.’

Photo Credit: Reuters

अदार पूनावाला 5

Corona Risk after Vaccination: Corona, Poonawala explain reason for people getting vaccine

Many people have complained of auto immune disorder after the vaccine. Adar Poonawala said, ‘First, a doctor can answer this question better than a doctor who comes across such a case. But I can say that no vaccine traditionally affects people whose immune system does not make antibodies, nor does it respond to a vaccine, just as their body does not respond to a disease. In the case of people who have this kind of disorder and people who are on cancer or any other kind of medicine that compresses their immune system, the vaccine can or may not affect them, but I can say that it does not increase their disorder.’

अदार पूनावाला 6

Both British and European regulators have expressed concern over the vaccine being given to adults. Adar Poonawala said, ‘It is difficult for any government or vaccine manufacturing company to answer this question. Firstly, there is a lot of dependence on global supply on the Indian vaccine industry. Secondly, covid cases are on the rise in India. In such a situation, our priority is to meet India’s needs and give all our consignments to India. For this, we have also faced the wrath of many global leaders. We have also had to side-side our international contract. But for us, countries are first and this is a temporary situation.’

Photo Credit: Getty Images

अदार पूनावाला 7

‘The second question is whether everyone should provide this vaccine or it should be available from a free channel, it is a tricky question. We have a vaccine supply shortage, and in the meantime we will open up the availability of the vaccine to all, it will affect sensitive people. Health Secretary Rajesh Bhushan has also stated that ensuring availability of vaccine to people below 45 years of age is not an easy decision. Now the question is, when other countries can do so, why can’t we compare our population with any other country? In such a situation, if it comes to opening a vaccine for the corporate, private market, I would say yes as the owner of a company, but from the point of view of the government and the poor people, it would not be correct because the Government has to strike a balance between the needs of lower, middle and upper class,’

Photo Credit: Reuters

अदार पूनावाला 8

On Covidshield’s efficiency over covid’s new mutants and variants, Poonawala said, ‘The study in this case is continuing. Especially about the UK variant that is now spreading in our country. We are collecting data from people who have taken one or two doses of covidshield and have come in contact with uk variants. We’ll be able to answer it correctly after a month because the data study is underway. Hopefully those who have taken the covidshield will not have to be hospitalized. There is no vaccine that prevents covid-19 from happening, in some cases these vaccines can do so.

अदार पूनावाला 9

In 95% of cases of pfizer, moderna or covidshield vaccine, it is that you will get the disease but you will not have to go to the hospital, he said. We are also seeing the same thing with uk variants and south african variants. I can say with confidence that not a single case has come to light where someone has taken the vaccine and has contracted UK variant and then had to go to the hospital. We have to wait another month for the rest and the whole study.’

Photo Credit: Getty Images

अदार पूनावाला 12

How much the edge factor in the vaccine matters. On this, he said, “We are thinking of trialing children below 18 years of age up to 12 years of age and a little younger, but we haven’t applied for it yet. It has started in the UK. In India, we probably have to do it with greater security. For covidshield, I estimate it will take at least six months to show that it is safe for children up to 12 or 10 years of age. But we have to keep in mind that children’s immune system is different from that of adults. In that case, we cannot take a chance to endanger even a single percent of a child’s life. For this, we need to take care of the dose given to them and the quantity thereof.’

Photo Credit: Reuters

अदार पूनावाला 13

 

Will the third dose be needed after two doses? On this, Adar Poonawala said, ‘Some vaccine companies have started talking about the third dose. We’re also considering it. The data we have so far shows that even after two doses you get at least 7 to 8 months of protection. We don’t know what happens after 8 months because vaccination hasn’t had that long.’

Photo Credit: Reuters

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

close